139 related articles for article (PubMed ID: 20512116)
21. Comparison of the hybrid capture II assay with the human papillomavirus DNA chip test for the detection of high-grade cervical lesions.
Kang WD; Kim CH; Cho MK; Kim JW; Kim YH; Choi HS; Kim SM
Int J Gynecol Cancer; 2009 Jul; 19(5):924-8. PubMed ID: 19574786
[TBL] [Abstract][Full Text] [Related]
22. Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.
Ibáñez R; Moreno-Crespi J; Sardà M; Autonell J; Fibla M; Gutiérrez C; Lloveras B; Alejo M; Català I; Alameda F; Casas M; Bosch FX; de Sanjosé S
BMC Infect Dis; 2012 Jan; 12():25. PubMed ID: 22280073
[TBL] [Abstract][Full Text] [Related]
23. Case-control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis.
Gillio-Tos A; Bicalho Mda G; Fiano V; Grasso C; Tarallo V; De Marco L; Trevisan M; Xavier M; Slowik R; Carvalho NS; Maestri CA; Lacerda HM; Zugna D; Richiardi L; Merletti F
BMC Cancer; 2012 Dec; 12():618. PubMed ID: 23265140
[TBL] [Abstract][Full Text] [Related]
24. Role of
Kremer WW; Berkhof J; Bleeker MC; Heideman DA; van Trommel NE; van Baal MW; Verhoeve HR; Meijer CJ; Kenter GG
BMJ Open; 2019 Jul; 9(7):e029017. PubMed ID: 31289088
[TBL] [Abstract][Full Text] [Related]
25. Potential impact of combined high- and low-risk human papillomavirus infection on the progression of cervical intraepithelial neoplasia 2.
Okadome M; Saito T; Tanaka H; Nogawa T; Furuta R; Watanabe K; Kita T; Yamamoto K; Mikami M; Takizawa K;
J Obstet Gynaecol Res; 2014 Feb; 40(2):561-9. PubMed ID: 24147758
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study.
Pista A; de Oliveira CF; Lopes C; Cunha MJ;
Int J Gynecol Cancer; 2013 Mar; 23(3):500-6. PubMed ID: 23392401
[TBL] [Abstract][Full Text] [Related]
27. Risk stratification of cervical lesions using capture sequencing and machine learning method based on HPV and human integrated genomic profiles.
Tian R; Cui Z; He D; Tian X; Gao Q; Ma X; Yang JR; Wu J; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Zhong H; Fan W; Chen Y; Jin Z; Cao C; Yu M; Xie W; Huang Z; Bao Y; Xie H; Yao S; Hu Z
Carcinogenesis; 2019 Oct; 40(10):1220-1228. PubMed ID: 31102403
[TBL] [Abstract][Full Text] [Related]
28. Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.
van Baars R; Griffin H; Wu Z; Soneji YJ; van de Sandt M; Arora R; van der Marel J; Ter Harmsel B; Jach R; Okon K; Huras H; Jenkins D; Quint W; Doorbar J
Am J Surg Pathol; 2015 Nov; 39(11):1518-1528. PubMed ID: 26379150
[TBL] [Abstract][Full Text] [Related]
29. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
Song F; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
BMC Cancer; 2022 Jan; 22(1):42. PubMed ID: 34991494
[TBL] [Abstract][Full Text] [Related]
30. Risk evaluation for the development of cervical intraepithelial neoplasia: development and validation of risk-scoring schemes.
Lee CH; Peng CY; Li RN; Chen YC; Tsai HT; Hung YH; Chan TF; Huang HL; Lai TC; Wu MT
Int J Cancer; 2015 Jan; 136(2):340-9. PubMed ID: 24841989
[TBL] [Abstract][Full Text] [Related]
31. [Detection and genetic typing of human papillomaviruses in cervical biopsies in Cagliari Province].
Laconi S; Greco M; Pellegrini-Bettoli P; Pani P; Laconi E; Rais M
Pathologica; 2000 Aug; 92(4):236-40. PubMed ID: 11029883
[TBL] [Abstract][Full Text] [Related]
32. Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124-2 methylation.
Leeman A; Ebisch RMF; Kasius A; Bosgraaf RP; Jenkins D; van de Sandt MM; de Strooper LMA; Heideman DAM; Snijders PJF; Massuger LFAG; Bekkers RLM; Meijer CJLM; van Kemenade FJ; Quint WGV; Melchers WJG
Gynecol Oncol; 2018 Nov; 151(2):311-318. PubMed ID: 30219239
[TBL] [Abstract][Full Text] [Related]
33. High-grade CIN on cervical biopsy and predictors of the subsequent cone histology results in women undergoing immediate conization.
Giannella L; Mfuta K; Gardini G; Rubino T; Fodero C; Prandi S
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():68-74. PubMed ID: 25656975
[TBL] [Abstract][Full Text] [Related]
34. Multiple HPV 16 infection with two strains: a possible marker of neoplastic progression.
Bruno MT; Scalia G; Cassaro N; Boemi S
BMC Cancer; 2020 May; 20(1):444. PubMed ID: 32429930
[TBL] [Abstract][Full Text] [Related]
35. Blimp-1 is a prognostic indicator for progression of cervical intraepithelial neoplasia grade 2.
Saito M; Rajesh A; Innes C; van der Griend R; Fitzgerald P; Simcock B; Sykes P; Hibma M
J Cancer Res Clin Oncol; 2022 Aug; 148(8):1991-2002. PubMed ID: 35386001
[TBL] [Abstract][Full Text] [Related]
36. Down-regulated nucleoside diphosphate kinase nm23-H1 expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancer.
Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Ruutu M; Favalli C; Syrjänen K;
J Clin Pathol; 2006 Oct; 59(10):1044-51. PubMed ID: 16537673
[TBL] [Abstract][Full Text] [Related]
37. Presence of multiple human papillomavirus types in cervical samples from HIV-infected women.
Levi JE; Fernandes S; Tateno AF; Motta E; Lima LP; Eluf-Neto J; Pannuti CS
Gynecol Oncol; 2004 Jan; 92(1):225-31. PubMed ID: 14751163
[TBL] [Abstract][Full Text] [Related]
38. Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study cohorts.
Syrjänen K; Shabalova I; Naud P; Kozachenko V; Derchain S; Zakharchenko S; Roteli-Martins C; Nerovjna R; Longatto-Filho A; Kljukina L; Tatti S; Branovskaja M; Hammes LS; Branca M; Grunjberga V; Erzen M; Sarian LO; Juschenko A; Costa S; Podistov J; Syrjänen S;
Int J Gynecol Cancer; 2009 Jul; 19(5):934-42. PubMed ID: 19574788
[TBL] [Abstract][Full Text] [Related]
39. HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable with a smear taken by a clinician or a brush-based self-sample: cross-sectional data from a triage population.
Leeman A; Del Pino M; Molijn A; Rodriguez A; Torné A; de Koning M; Ordi J; van Kemenade F; Jenkins D; Quint W
BJOG; 2017 Aug; 124(9):1356-1363. PubMed ID: 28391609
[TBL] [Abstract][Full Text] [Related]
40. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]